“Raised CRP”的搜索结果，显示 61-70 项，共有 5758 项

1. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... high and very high risk relapsed FHWT (those treated with 3 or more drugs for the initial WT). 3D Ultrasound for the Imaging of Axillary Lymph Nodes in ...

2. 神经科- 临床试验- 妙佑医疗国际

   ... high (80-90%) frequency of MUC1 expression and variably high (unreported to 50%) HER2/neu (“HER2”) expression; (2) Cohort 2 focuses on primary or secondary ...

3. 神经科- 临床试验- 妙佑医疗国际

   ... high (80-90%) frequency of MUC1 expression and variably high (unreported to 50%) HER2/neu (“HER2”) expression; (2) Cohort 2 focuses on primary or secondary ...

4. 神经科- 临床试验- 妙佑医疗国际

   ... high (80-90%) frequency of MUC1 expression and variably high (unreported to 50%) HER2/neu (“HER2”) expression; (2) Cohort 2 focuses on primary or secondary ...

5. 血液科- 临床试验- 妙佑医疗国际

   This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic ...

6. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Giving high dose chemotherapy followed by an autologous stem cell transplant may be more effective compared to observation only in treating patients with ...

7. 外科 - 临床试验- 妙佑医疗国际

   Surgeons As High-Performance Athletes. Rochester, Minn. The purpose of this prospective observational study is to gather and evaluate the evidence for attending ...

8. 神经科- 临床试验- 妙佑医疗国际

   ... high (80-90%) frequency of MUC1 expression and variably high (unreported to 50%) HER2/neu (“HER2”) expression; (2) Cohort 2 focuses on primary or secondary ...

9. 血液科- 临床试验- 妙佑医疗国际

   This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic ...

10. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

    Usual treatment after a complete response may include observation or high dose chemotherapy followed by an autologous stem cell transplant, however, it is not ...